PFBC posts

Feed

Analyst Upgrades, Downgrades and Initiations: PFBC, PTRY, VQ, WBD

Analyst Upgrades

  • Citigroup upgraded Wimm-Bill-Dann (WBD) to buy from hold.

Analyst Downgrades

  • FBR downgraded Preferred Bank (PFBC) to underperform from market perform after the company said it would restate earnings. The firm lowered its price target on shares to $1.50 from $4.

Analyst Initiations

  • Global Hunter initiated Venoco (VQ) with a buy. Global Hunter sees several potential catalysts for Venoco in 2010 with the company employing horizontal drilling onshore California. The firm has a $20 target on the shares.
  • Global Hunter initiated Pantry (PTRY) with a neutral. Global Hunter cites near-term gross margin concerns for its Neutral rating on Pantry. The firm has a $15.50 target on shares.

Analyst calls: AMR, JCG, AMLN, NGG . . .

Analyst upgrades:

  • Goldman upgraded shares of British Sky Broadcasting (NYSE: BSY) to Buy from Neutral and added the company to the Conviction Buy List as they find the stock oversold at current levels.
  • Goldman also added Publicis (OTC: PUBGY) to the Conviction Buy List and upgraded shares to Buy from Neutral as they find the stock cheap at current levels.
  • Oneok (NYSE: OKE) was upgraded to Overweight from Equal Weight at Lehman.
  • UBS raised Wimm-Bill-Dann Foods (NYSE: WBD) to Buy from Neutral.

Analyst downgrades:

  • Baird downgraded Amylin Pharma (NASDAQ: AMLN) to Neutral from Outperform and said they are incrementally more cautious on the commercial performance of Amylin's Byetta following the yesterday's update. Amylin's target was lowered to $27 from $37. Soleil recommends investors avoid Amylin with the disclosure last night of four additional cases of mortality associated with pancreatitis in patients who were on Byetta. The firm cut shares to Sell from Hold and lowered their target to $20 from $25.
  • Citigroup downgraded shares of AMR Corp. (NYSE: AMR) to Sell from Hold on valuation as they find the stock expensive following the recent run-up. The firm raised their target to $9 from $6.70 to reflect the drop in crude prices.
  • J Crew (NYSE: JCG) was downgraded to Hold from Buy at Brean Murray following the weak Q2 report and guidance.
  • JMP Securities downgraded Quality Systems (NASDAQ: QSII) to Market Perform from Outperform.
  • National Grid (NYSE: NGG) was lowered to Equal Weight from Overweight at Lehman.

Analyst initiations:

Continue reading Analyst calls: AMR, JCG, AMLN, NGG . . .

Analyst upgrades: CRBC, HES, STEL, PFBC, AG, SLM and SAFM

MOST NOTEWORTHY: Citizens Republic Bancorp, Hess Corp and Sanderson Farms were today's noteworthy upgrades:
  • Keefe Bruyette upgraded shares of Citizens Republic Bancorp (NASDAQ: CRBC) to Outperform from Market Perform on valuation following yesterday's sell-off, which they attribute in part to its removal from the Dow Jones Select Dividend Index. Shares were also raised to OUtperform from Perform at Oppenheimer following the sell-off.
  • Goldman upgraded Hess (NYSE: HES) to Buy from Neutral citing the company's leverage to higher oil prices. The firm said oil is likely to hit $150-$200/bbl in the next 6-24 months.
  • Stephens upgraded shares of Sanderson Farms (NASDAQ: SAFM) to Overweight from Equal Weight as they expect industry fundamentals to improve in FY09.
OTHER UPGRADES:
  • Baird raised Stellent (NASDAQ: STEL) to OUtperform from Neutral.
  • Friedman Billings upgraded Preferred Bank (NASDAQ: PFBC) to Market Perform from Underperform.
  • Agco (NYSE: AG) was upgraded at Goldman to Buy from Neutral.
  • Lehman upgraded SLM Corp (NYSE: SLM) to Overweight from Equal Weight.

Analyst initiations 6-06-07: AW, RSG and WMI

MOST NOTEWORTHY: The environmental services sector, the machinery and capital goods sector and several bank holding companies were today's noteworthy initiations:
OTHER INITIATIONS:
  • Golfsmith International Holdings Inc (NASDAQ: GOLF) was initiated at Wedbush with a Buy rating and $8.75 target, as the firm believes the company is an attractive growth story and buyout candidate.
  • Pharmasset Inc (NASDAQ: VRUS) was initiated with a Buy rating and $12 target at Banc of America, as the firm believes Clevudine has the potential to be best in class for the treatment of the hepatitis B virus.
  • Ciena Corporation (NASDAQ: CIEN) was initiated with an Outperform rating and $40 target at Piper Jaffray.

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 11, 2012: 12:12 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1328937122005 ms.